医薬品添加剤市場 : 2028年までの世界予測

Report Overview

The global pharmaceutical excipients market is projected to reach USD 14.9 Bn by 2028 from USD 10.7 Bn in 2023, at a CAGR of 6.8% during the forecast period of 2023 to 2028. Factors such as the rising pharmaceutical products and generics demand and R&D investments for novel excipient development are predicted to uplift the market in the coming years. Additionally, partnerships and collaboration with pharmaceutical companies and increased emphasis on patient-centric formulations will provide lucrative market growth. However, regulatory stringency and steep development costs are predicted to restrict the market.

“The fillers & diluents functionality held the dominant share in the pharmaceutical excipients market.”
Based on functionality, the global pharmaceutical excipients market is segmented into binders, suspending & viscosity agents, fillers & diluents, flavoring agents & sweeteners, colorants, coating agents, lubricants & glidants, preservatives, disintegrants, emulsifying agents, and other functionalities. The growing demand for fillers and diluents in the development and production of solid oral drugs is expected to drive the expansion of the fillers and diluents market. For manufacturers, fillers and diluents provide stability and facilitate preparation, packaging, shipping, and dispensing. For patients, they enhance the palatability of the formulation and simplify administration and handling of the medication.

“Oral formulations segment accounted for the largest share of the formulations segment in 2022.”
Based on formulations, the pharmaceutical excipients market is segmented into oral formulations, topical forumlations, parenteral formulations and other forumaltions. In 2022, the oral formulations segment accounted for the largest share of the pharmaceutical excipients market. The rapidly growing biopharmaceutical and generics industries are the primary drivers of growth for the pharmaceutical excipients market. Additionally, the oral route of administration is the most prevalent and traditional mode of drug delivery, which has also contributed to the segment’s growth.

“Asia Pacific region is likely to grow at a faster pace.”
The pharmaceutical excipients market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Asia Pacific region is anticipated to grow at a significant CAGR during the forecast period. Low-cost manufacturing advantage, low regulatory stringency, and increasing per capita income support the growth of the pharmaceutical excipients market in the region.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80%, and Demand Side – 20%
• By Designation (Supply Side): Managers – 45%, CXOs & Directors – 30%, Executives- 25%
• By Region: North America -20%, Europe -10%, Asia-Pacific -55%, Latin America -10%, MEA- 5%
List of Companies Profiled in the Report:
• International Flavors & Fragrances Inc. (US)
• Ashland Inc. (US)
• Evonik Industries AG (Germany)
• BASF SE (Germany)
• Kerry Group plc (Ireland)
• Roquette Frères (France)
• MERCK KGaA (Germany)
• Associated British Foods plc (UK)
• ADM (US)
• Wacker Chemie AG (Germany)
• Air Liquide (France)
• DOW (US)
• Berkshire Hathaway Inc. (US)
• Colorcon (US)
• DFE PHARMA (Germany)
• Innophos (US)
• JRS PHARMA (Germany)
• Actylis (US)
• Meggle GmbH & Co Kg (Germany)
• Corel Pharma Chem. (India)
• Biogrund GmbH (Germany)
• Nitika Pharmaceutical Specialities Pvt. Ltd. (India)
• BENEO (Germany)
• Fuji Chemical Industries Co., Ltd. (Japan)
• R.T. Vanderbilt Holding Company, Inc. (US)

Research Coverage:
This report provides a detailed picture of the pharmaceutical excipients market. It aims to estimate the size and future growth potential of the market across different segments, such as product, functionality, formulation, functionality application and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall pharmaceutical excipients market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (Increasing demand for generic drugs and pharmaceutical products, increased R&D Investments for the development of novel excipients, growing emphasis on patient-centric formulations, collaborations and partnerships with pharmaceutical companies), restraints (Stringent Regulatory Requirements, High Development Costs), opportunities (Rising demand for functional/multifunctional pharmaceutical excipients, advancements in nanotechnology, emerging markets in Asia-Pacific and Latin America) and challenges (Safety & quality concerns, limited availability of certain raw materials) are influencing the growth of pharmaceutical excipients market.
• Product Development/Innovation: Detailed insights on newly launched products of the pharmaceutical excipients market.
• Functionality Apllication: Additional segment provided for functionality applications where segregation has been provided based on the applications of various excipients highlights the various uses of different excipients classes.
• Market Development: Comprehensive information about lucrative markets – the report analyses the pharmaceutical excipients market across varied regions.
• Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the pharmaceutical excipients market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players include International Flavors & Fragrances Inc. (US), Ashland Inc. (US), Evonik Industries AG (Germany), BASF SE (Germany), Kerry Group plc (Ireland), Roquette Frères (France), MERCK KGaA (Germany),  Associated British Foods plc (UK), ADM (US), Wacker Chemie AG (Germany) and among others in the pharmaceutical excipients market. 

Table of Contents

1            INTRODUCTION            44

1.1         STUDY OBJECTIVES      44

1.2         MARKET DEFINITION   44

1.2.1      INCLUSIONS AND EXCLUSIONS 44

1.3         MARKET SCOPE             45

1.3.1      MARKETS COVERED     45

1.3.2      YEARS CONSIDERED     46

1.3.3      CURRENCY CONSIDERED          46

1.4         STAKEHOLDERS            46

1.5         SUMMARY OF CHANGES            47

1.5.1      RECESSION IMPACT      48

2            RESEARCH METHODOLOGY     49

2.1         RESEARCH DATA           49

FIGURE 1           RESEARCH DESIGN       49

2.1.1      SECONDARY DATA       50

2.1.2      PRIMARY DATA 51

FIGURE 2           BREAKDOWN OF PRIMARIES     51

2.2         MARKET SIZE ESTIMATION       52

FIGURE 3           MARKET SIZE ESTIMATION: PHARMACEUTICAL EXCIPIENTS MARKET (2022) 52

FIGURE 4           APPROACH 1: REVENUE SHARE ANALYSIS          53

FIGURE 5           REVENUE SHARE ANALYSIS OF INTERNATIONAL FLAVORS & FRAGRANCES INC.: PHARMACEUTICAL EXCIPIENTS MARKET (2022)      53

2.2.1      PRIMARY INSIGHTS       54

FIGURE 6           MARKET VALIDATION FROM PRIMARY EXPERTS           54

2.2.2      SEGMENTAL ASSESSMENT: PHARMACEUTICAL EXCIPIENTS MARKET              55

FIGURE 7           MARKET SIZE ESTIMATION: TOP-DOWN APPROACH    55

2.3         GROWTH RATE ASSUMPTIONS 56

FIGURE 8           CAGR PROJECTION: PHARMACEUTICAL EXCIPIENTS MARKET              56

FIGURE 9           GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES  57

2.4         MARKET BREAKDOWN & DATA TRIANGULATION          58

FIGURE 10         DATA TRIANGULATION METHODOLOGY         58

2.5         STUDY ASSUMPTIONS  59

2.6         RESEARCH LIMITATIONS           59

2.7         RISK ANALYSIS 60

2.8         RECESSION IMPACT: PHARMACEUTICAL EXCIPIENTS MARKET 60

TABLE 1             GLOBAL INFLATION RATE PROJECTION, 2021–2028 (% GROWTH)         61

TABLE 2             US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)  61

TABLE 3             US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)  61

3            EXECUTIVE SUMMARY 62

FIGURE 11         PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)             62

FIGURE 12         PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION) 63

FIGURE 13         PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028 (USD MILLION)     64

FIGURE 14         PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028 (USD MILLION)  64

FIGURE 15         PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHICAL SNAPSHOT        65

4            PREMIUM INSIGHTS      66

4.1         PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW   66

FIGURE 16         GROWTH IN GENERICS AND PHARMACEUTICAL PRODUCT DEMAND TO DRIVE MARKET GROWTH 66

4.2         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET     67

FIGURE 17         ORGANIC CHEMICALS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022      67

4.3         PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           67

FIGURE 18         CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD              67

5            MARKET OVERVIEW     68

5.1         INTRODUCTION            68

5.2         MARKET DYNAMICS     68

FIGURE 19         PHARMACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       68

TABLE 4             PHARMACEUTICAL EXCIPIENTS MARKET: IMPACT ANALYSIS              69

5.2.1      DRIVERS            69

5.2.1.1   Increasing demand for generic drugs and pharmaceutical products          69

TABLE 5             BRAND NAMES AND GENERIC COUNTERPARTS             70

5.2.1.2   Increased R&D investments to develop novel excipients            71

FIGURE 20         GLOBAL PHARMACEUTICAL DRUG SALES (2008–2022)  71

5.2.1.3   Growing emphasis on patient-centric formulations to fuel demand for specialized excipients            72

5.2.1.4   Collaborations and partnerships with pharmaceutical companies for customized excipient solutions             72

5.2.2      RESTRAINTS     73

5.2.2.1   Stringent regulatory requirements   73

5.2.2.2   High development costs     74

5.2.3      OPPORTUNITIES           74

5.2.3.1   Rising demand for functional/multifunctional pharmaceutical excipients 74

TABLE 6             MULTIFUNCTIONAL EXCIPIENTS          75

5.2.3.2   Advancements in nanotechnology    76

5.2.3.3   Emerging markets in Asia Pacific and Latin America   77

5.2.4      CHALLENGES   78

5.2.4.1   Safety and quality concerns              78

5.2.4.2   Limited availability of certain raw materials used in excipient production 78

5.3         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 79

FIGURE 21         REVENUE SHIFT AND NEW POCKETS FOR PHARMACEUTICAL EXCIPIENT PROVIDERS 79

5.4         PRICING ANALYSIS        80

TABLE 7             PRICING ANALYSIS (USD)          80

5.5         VALUE CHAIN ANALYSIS            80

FIGURE 22         PHARMACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS          82

FIGURE 23         PHARMACEUTICAL EXCIPIENTS MARKET: SUPPLY CHAIN ANALYSIS          83

5.6         ECOSYSTEM/MARKET MAP       84

FIGURE 24         PHARMACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM/MARKET MAP       84

TABLE 8             SUPPLY CHAIN ECOSYSTEM      84

5.7         TECHNOLOGY ANALYSIS           86

5.8         PATENT ANALYSIS        87

FIGURE 25         PHARMACEUTICAL EXCIPIENTS MARKET: PATENT ANALYSIS              87

5.8.1      LIST OF MAJOR PATENTS          88

TABLE 9             PHARMACEUTICAL EXCIPIENTS MARKET: MAJOR PATENTS              88

5.9         KEY CONFERENCES & EVENTS IN 2023–2024       89

TABLE 10           PHARMACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF EVENTS AND CONFERENCES    89

5.10       TRADE DATA    90

5.10.1    GLYCEROL        90

TABLE 11           HS CODE: 290545 GLYCEROL     90

5.10.2    DEXTRINS AND OTHER MODIFIED STARCHES  92

TABLE 12           HS CODE: 350510 DEXTRINS AND OTHER MODIFIED STARCHES (E.G., PREGELATINIZED OR ESTERIFIED STARCHES)     92

5.10.3    PROPYLENE GLYCOL    94

TABLE 13           HS CODE: 290532 PROPYLENE GLYCOL (PROPANE-1,2-DIOL)              94

5.10.4    CALCIUM CARBONATE 96

TABLE 14           HS CODE: 283650 CALCIUM CARBONATE            96

5.10.5    SODIUM CHLORIDE      98

TABLE 15           HS CODE: 250100 SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE, WHETHER OR NOT IN AQUEOUS SOLUTION OR CONTAINING ADDED ANTI-CAKING OR FREE-FLOWING AGENTS; SEA WATER    98

5.10.6    MANNITOL       100

TABLE 16           HS CODE: 290543 MANNITOL    100

5.10.7    CELLULOSE      102

TABLE 17           HS CODE: 3912 CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS         102

5.11       TARIFF AND REGULATORY LANDSCAPE            103

5.11.1    REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS          103

5.11.1.1 FDA regulations on pharmaceutical excipients             103

5.11.2    LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          104

5.11.2.1 North America     104

TABLE 18           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         104

5.11.2.2 Europe  105

TABLE 19           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 105

5.11.2.3 Asia Pacific          106

TABLE 20           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         106

5.11.2.4 Latin America      106

TABLE 21           LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         106

5.11.2.5 Middle East & Africa          107

TABLE 22           MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         107

5.12       PORTER’S FIVE FORCES ANALYSIS         107

TABLE 23           PHARMACEUTICAL EXCIPIENTS MARKET: PORTER’S FIVE FORCES ANALYSIS         107

5.12.1    THREAT OF NEW ENTRANTS    107

5.12.2    THREAT OF SUBSTITUTES         107

5.12.3    BARGAINING POWER OF BUYERS           108

5.12.4    BARGAINING POWER OF SUPPLIERS     108

5.12.5    DEGREE OF COMPETITION       108

5.13       KEY STAKEHOLDERS AND BUYING CRITERIA    108

5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS         108

FIGURE 26         INFLUENCE OF COMPANY STAKEHOLDERS IN BUYING PROCESS OF PHARMACEUTICAL EXCIPIENTS   108

5.13.2    KEY BUYING CRITERIA FOR PHARMACEUTICAL EXCIPIENTS PRODUCTS AMONG END USERS             109

FIGURE 27         KEY BUYING CRITERIA FOR END USERS              109

6            PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT            110

6.1         INTRODUCTION            111

TABLE 24           PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     111

6.2         ORGANIC CHEMICALS  111

TABLE 25           PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)            111

TABLE 26           PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY REGION, 2021–2028 (USD MILLION)      112

TABLE 27           NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)    112

TABLE 28           EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)            112

TABLE 29           ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)            113

TABLE 30           LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)    113

6.2.1      OLEOCHEMICALS         113

TABLE 31           OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          114

TABLE 32           OLEOCHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION)          114

TABLE 33           NORTH AMERICA: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          114

TABLE 34           EUROPE: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 115

TABLE 35           ASIA PACIFIC: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     115

TABLE 36           LATIN AMERICA: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          115

6.2.1.1   Fatty alcohols      116

6.2.1.1.1 Wide usage as nonionic surfactants to drive market      116

TABLE 37           FATTY ALCOHOLS MARKET, BY REGION, 2021–2028 (USD MILLION)          116

TABLE 38           NORTH AMERICA: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          117

TABLE 39           EUROPE: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117

TABLE 40           ASIA PACIFIC: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          117

TABLE 41           LATIN AMERICA: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          118

6.2.1.2   Mineral stearates 118

6.2.1.2.1 High adoption of magnesium stearates as excipients in to drive market    118

TABLE 42           MINERAL STEARATES MARKET, BY REGION, 2021–2028 (USD MILLION)          118

TABLE 43           NORTH AMERICA: MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    119

TABLE 44           EUROPE: MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     119

TABLE 45           ASIA PACIFIC MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          119

TABLE 46          LATIN AMERICA: MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          120

6.2.1.3   Glycerin 120

6.2.1.3.1 Extensive applications of glycerin to drive market        120

TABLE 47           GLYCERIN MARKET, BY REGION, 2021–2028 (USD MILLION)              120

TABLE 48           NORTH AMERICA: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     121

TABLE 49           EUROPE: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          121

TABLE 50           ASIA PACIFIC: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121

TABLE 51           LATIN AMERICA: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122

6.2.1.4   Other oleochemicals          122

TABLE 52           OTHER OLEOCHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION) 122

TABLE 53           NORTH AMERICA: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    123

TABLE 54           EUROPE: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          123

TABLE 55           ASIA PACIFIC: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    123

TABLE 56           LATIN AMERICA: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    124

6.2.2      CARBOHYDRATES         124

TABLE 57           CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          125

TABLE 58           CARBOHYDRATES MARKET, BY REGION, 2021–2028 (USD MILLION)          125

TABLE 59           NORTH AMERICA: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          125

TABLE 60           EUROPE: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126

TABLE 61           ASIA PACIFIC: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     126

TABLE 62           LATIN AMERICA: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          126

6.2.2.1   Sugars    127

TABLE 63           SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)  127

TABLE 64           SUGARS MARKET, BY REGION, 2021–2028 (USD MILLION)              127

TABLE 65           NORTH AMERICA: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128

TABLE 66           EUROPE: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          128

TABLE 67           ASIA PACIFIC: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          128

TABLE 68           LATIN AMERICA: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129

6.2.2.2   Actual sugars       129

6.2.2.2.1 Growing use of actual sugars in pediatric formulations to drive market    129

TABLE 69          PHARMACEUTICAL EXCIPIENTS MARKET, BY ACTUAL SUGARS, 2021–2028 (USD MILLION)          130

TABLE 70           ACTUAL SUGARS MARKET, BY REGION, 2021–2028 (USD MILLION)          130

TABLE 71           NORTH AMERICA: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          131

TABLE 72           EUROPE: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131

TABLE 73           ASIA PACIFIC: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     131

TABLE 74           LATIN AMERICA: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          132

6.2.2.3   Sugar alcohols     132

6.2.2.3.1 Mannitol to show highest growth in sugar alcohols market         132

TABLE 75           PHARMACEUTICAL EXCIPIENTS MARKET, BY SUGAR ALCOHOLS, 2021–2028 (USD MILLION)  133

TABLE 76           SUGAR ALCOHOLS MARKET, BY REGION, 2021–2028 (USD MILLION)          133

TABLE 77           NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          133

TABLE 78           EUROPE: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134

TABLE 79           ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          134

TABLE 80           LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          134

6.2.2.4   Artificial sweeteners          135

6.2.2.4.1 Wide usage of aspartame to ensure sustained growth   135

TABLE 81           ARTIFICIAL SWEETENERS MARKET, BY REGION, 2021–2028 (USD MILLION) 136

TABLE 82           NORTH AMERICA: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    136

TABLE 83           EUROPE: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          136

TABLE 84           ASIA PACIFIC: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    137

TABLE 85           LATIN AMERICA: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    137

6.2.2.5   Cellulose             137

TABLE 86           CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)              138

TABLE 87           CELLULOSE MARKET, BY REGION, 2021–2028 (USD MILLION)              138

TABLE 88           NORTH AMERICA: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     138

TABLE 89           EUROPE: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          139

TABLE 90           ASIA PACIFIC: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139

TABLE 91           LATIN AMERICA: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     139

6.2.2.6   Microcrystalline cellulose   140

6.2.2.6.1 Microcrystalline cellulose to hold largest share             140

TABLE 92           MICROCRYSTALLINE CELLULOSE MARKET, BY REGION, 2021–2028 (USD MILLION)     140

TABLE 93           NORTH AMERICA: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            141

TABLE 94           EUROPE: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    141

TABLE 95           ASIA PACIFIC: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    141

TABLE 96           LATIN AMERICA: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            142

6.2.2.7   Cellulose ethers   142

6.2.2.7.1 Effectiveness in low concentrations to propel usage      142

TABLE 97           CELLULOSE ETHERS MARKET, BY REGION, 2021–2028 (USD MILLION)          143

TABLE 98           NORTH AMERICA: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    143

TABLE 99           EUROPE: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     143

TABLE 100         ASIA PACIFIC: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          144

TABLE 101         LATIN AMERICA: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          144

6.2.2.8   CMC & croscarmellose sodium        144

6.2.2.8.1 Advantages to ensure wide usage as suspending agents in injectable preparations              144

TABLE 102         CMC & CROSCARMELLOSE SODIUM MARKET, BY REGION, 2021–2028 (USD MILLION)          145

TABLE 103         NORTH AMERICA: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         145

TABLE 104         EUROPE: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    146

TABLE 105         ASIA PACIFIC: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    146

TABLE 106         LATIN AMERICA: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            146

6.2.2.9   Cellulose esters    147

6.2.2.9.1 Wide usage in pharma applications to support market growth    147

TABLE 107         CELLULOSE ESTERS MARKET, BY REGION, 2021–2028 (USD MILLION)          147

TABLE 108        NORTH AMERICA: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          147

TABLE 109         EUROPE: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     148

TABLE 110         ASIA PACIFIC: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          148

TABLE 111         LATIN AMERICA: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          148

6.2.2.10 Starch    149

TABLE 112         STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)  149

TABLE 113         STARCH MARKET, BY REGION, 2021–2028 (USD MILLION)              149

TABLE 114         NORTH AMERICA: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 150

TABLE 115         EUROPE: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          150

TABLE 116         ASIA PACIFIC: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          150

TABLE 117         LATIN AMERICA: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 151

6.2.2.11 Modified starch    151

6.2.2.11.1            Wide use in sustained-release tablets attributed to cold-water swelling and gel barrier formation capabilities             151

TABLE 118         MODIFIED STARCH MARKET, BY REGION, 2021–2028 (USD MILLION)          152

TABLE 119         NORTH AMERICA: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          152

TABLE 120         EUROPE: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     152

TABLE 121         ASIA PACIFIC: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          153

TABLE 122         LATIN AMERICA: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          153

6.2.2.12 Dried starch         153

6.2.2.12.1            Strong binding and coating properties to favor demand growth  153

TABLE 123         DRIED STARCH MARKET, BY REGION, 2021–2028 (USD MILLION)          154

TABLE 124         NORTH AMERICA: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          154

TABLE 125         EUROPE: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 154

TABLE 126         ASIA PACIFIC: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     155

TABLE 127         LATIN AMERICA: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     155

6.2.2.13 Converted starch 155

6.2.2.13.1            Support for enhancing drug solubility and stability to propel adoption              155

TABLE 128         CONVERTED STARCH MARKET, BY REGION, 2021–2028 (USD MILLION)          156

TABLE 129         NORTH AMERICA: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    156

TABLE 130         EUROPE: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     156

TABLE 131         ASIA PACIFIC: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          157

TABLE 132         LATIN AMERICA: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    157

6.2.3      PETROCHEMICALS       157

TABLE 133         PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          158

TABLE 134         PETROCHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION)          158

TABLE 135         NORTH AMERICA: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          158

TABLE 136         EUROPE: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     159

TABLE 137         ASIA PACIFIC: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          159

TABLE 138         LATIN AMERICA: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          159

6.2.3.1   Glycols  160

6.2.3.1.1 Glycols to hold largest share of petrochemicals segment             160

TABLE 139         PHARMACEUTICAL EXCIPIENTS MARKET, BY GLYCOLS, 2021–2028 (USD MILLION)     160

TABLE 140         GLYCOLS MARKET, BY REGION, 2021–2028 (USD MILLION)              161

TABLE 141         NORTH AMERICA: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161

TABLE 142         EUROPE: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          161

TABLE 143         ASIA PACIFIC: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162

TABLE 144         LATIN AMERICA: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 162

6.2.3.2   Povidones            162

6.2.3.2.1 Rising demand for fast-dissolving tablets to propel market growth           162

TABLE 145         POVIDONES MARKET, BY REGION, 2021–2028 (USD MILLION)              163

TABLE 146         NORTH AMERICA: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     163

TABLE 147         EUROPE: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          163

TABLE 148         ASIA PACIFIC: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 164

TABLE 149         LATIN AMERICA: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     164

6.2.3.3   Mineral hydrocarbons        164

6.2.3.3.1 Growing preference for topical formulations in pain management to support demand for mineral hydrocarbons   164

TABLE 150         PHARMACEUTICAL EXCIPIENTS MARKET, BY MINERAL HYDROCARBONS, 2021–2028 (USD MILLION)     165

TABLE 151         MINERAL HYDROCARBONS MARKET, BY REGION, 2021–2028 (USD MILLION) 165

TABLE 152         NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    166

TABLE 153         EUROPE: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          166

TABLE 154         ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    166

TABLE 155         LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    167

6.2.3.4   Acrylic polymers  167

6.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive market   167

TABLE 156         ACRYLIC POLYMERS MARKET, BY REGION, 2021–2028 (USD MILLION)          167

TABLE 157         NORTH AMERICA: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    168

TABLE 158         EUROPE: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     168

TABLE 159         ASIA PACIFIC: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          168

TABLE 160         LATIN AMERICA: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          169

6.2.3.5   Other petrochemical excipients       169

TABLE 161         OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY REGION, 2021–2028 (USD MILLION)          170

TABLE 162         NORTH AMERICA: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         170

TABLE 163         EUROPE: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    171

TABLE 164         ASIA PACIFIC: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            171

TABLE 165         LATIN AMERICA: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         171

6.2.4      PROTEINS         172

6.2.4.1   Growing applications of proteins as carriers for microparticles and nanoparticles to drive market    172

TABLE 166         PROTEINS MARKET, BY REGION, 2021–2028 (USD MILLION)              172

TABLE 167         NORTH AMERICA: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     173

TABLE 168         EUROPE: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          173

TABLE 169         ASIA PACIFIC: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 173

TABLE 170         LATIN AMERICA: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 174

6.2.5      OTHER ORGANIC CHEMICALS  174

TABLE 171         OTHER ORGANIC CHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION) 174

TABLE 172         NORTH AMERICA: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    175

TABLE 173         EUROPE: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    175

TABLE 174         ASIA PACIFIC: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    175

TABLE 175         LATIN AMERICA: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    176

6.3         INORGANIC CHEMICALS            176

TABLE 176         PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)            176

TABLE 177         PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY REGION, 2021–2028 (USD MILLION)      177

TABLE 178         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 177

TABLE 179         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)        177

TABLE 180         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)        178

TABLE 181         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION) 178

6.3.1      CALCIUM PHOSPHATE 178

6.3.1.1   Chemical purity and low incompatibility with drugs to aid usage in pharma applications         178

TABLE 182         CALCIUM PHOSPHATE MARKET, BY REGION, 2021–2028 (USD MILLION)          179

TABLE 183         NORTH AMERICA: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    179

TABLE 184         EUROPE: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     179

TABLE 185         ASIA PACIFIC: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          180

TABLE 186         LATIN AMERICA: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    180

6.3.2      METAL OXIDES 180

6.3.2.1   Availability of silicon oxides in hydrophobic, hydrophilic, and granulated forms to aid market growth              180

TABLE 187         METAL OXIDES MARKET, BY REGION, 2021–2028 (USD MILLION)          181

TABLE 188         NORTH AMERICA: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          181

TABLE 189         EUROPE: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 181

TABLE 190         ASIA PACIFIC: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     182

TABLE 191         LATIN AMERICA: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     182

6.3.3      HALITES            182

6.3.3.1   Increased utilization in vaccines and controlled-release formulations to drive demand 182

TABLE 192         HALITES MARKET, BY REGION, 2021–2028 (USD MILLION)              183

TABLE 193         NORTH AMERICA: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 183

TABLE 194         EUROPE: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          183

TABLE 195         ASIA PACIFIC: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184

TABLE 196         LATIN AMERICA: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 184

6.3.4      CALCIUM CARBONATE 184

6.3.4.1   Short disintegration time and excellent mechanical strength for oral formulations to drive market    184

TABLE 197         CALCIUM CARBONATE MARKET, BY REGION, 2021–2028 (USD MILLION)          185

TABLE 198         NORTH AMERICA: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    185

TABLE 199         EUROPE: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     185

TABLE 200         ASIA PACIFIC: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          186

TABLE 201         LATIN AMERICA: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    186

6.3.5      CALCIUM SULFATE       186

6.3.5.1   Cost-effectiveness as diluent to support adoption        186

TABLE 202         CALCIUM SULFATE MARKET, BY REGION, 2021–2028 (USD MILLION)          187

TABLE 203         NORTH AMERICA: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          187

TABLE 204         EUROPE: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     187

TABLE 205         ASIA PACIFIC: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          188

TABLE 206         LATIN AMERICA: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          188

6.3.6      OTHER INORGANIC CHEMICALS            188

TABLE 207         OTHER INORGANIC CHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION)     189

TABLE 208         NORTH AMERICA: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            189

TABLE 209         EUROPE: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    189

TABLE 210         ASIA PACIFIC: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    190

TABLE 211         LATIN AMERICA: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    190

6.4         OTHER CHEMICALS      190

TABLE 212         PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY REGION, 2021–2028 (USD MILLION)      191

TABLE 213         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)        191

TABLE 214         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)   191

TABLE 215         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)   192

TABLE 216         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)        192

7            PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION   193

7.1         INTRODUCTION            194

TABLE 217         PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)          194

7.2         ORAL FORMULATIONS 194

TABLE 218         PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   195

TABLE 219         PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY REGION, 2021–2028 (USD MILLION)            195

TABLE 220         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)   195

TABLE 221         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)        196

TABLE 222         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)           196

TABLE 223         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)   196

7.2.1      TABLETS           197

7.2.1.1   Wide usage to drive market              197

TABLE 224         TYPICAL COMPOSITION OF TABLETS   197

TABLE 225         TABLETS MARKET, BY REGION, 2021–2028 (USD MILLION)              198

TABLE 226         NORTH AMERICA: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 198

TABLE 227         EUROPE: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          198

TABLE 228         ASIA PACIFIC: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 199

TABLE 229         LATIN AMERICA: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 199

7.2.2      CAPSULES         199

TABLE 230         CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)              200

TABLE 231         CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)              200

TABLE 232         NORTH AMERICA: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     200

TABLE 233         EUROPE: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          201

TABLE 234         ASIA PACIFIC: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 201

TABLE 235         LATIN AMERICA: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 201

7.2.2.1   Hard-gelatin capsules        202

7.2.2.1.1 Ease of manufacturing and versatility to drive market  202

TABLE 236         HARD-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 202

TABLE 237         NORTH AMERICA: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    202

TABLE 238         EUROPE: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          203

TABLE 239         ASIA PACIFIC: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    203

TABLE 240         LATIN AMERICA: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    203

7.2.2.2   Soft-gelatin capsules          204

7.2.2.2.1 Stability concerns with highly water-soluble compounds to restrict growth              204

TABLE 241         SOFT-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION) 204

TABLE 242         NORTH AMERICA: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    205

TABLE 243         EUROPE: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          205

TABLE 244         ASIA PACIFIC: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    205

TABLE 245         LATIN AMERICA: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    206

7.2.3      LIQUID FORMULATIONS           206

7.2.3.1   No dissolution time and rapid absorption to favor adoption       206

TABLE 246         LIQUID FORMULATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)          206

TABLE 247         NORTH AMERICA: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    207

TABLE 248         EUROPE: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          207

TABLE 249         ASIA PACIFIC: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    207

TABLE 250         LATIN AMERICA: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    208

7.2.4      OTHER ORAL FORMULATIONS 208

TABLE 251         OTHER ORAL FORMULATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)     209

TABLE 252         NORTH AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    209

TABLE 253         EUROPE: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    209

TABLE 254         ASIA PACIFIC: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    210

TABLE 255         LATIN AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    210

7.3         TOPICAL FORMULATIONS        210

7.3.1      ADVANTAGES OF TOPICAL DRUG DELIVERY TO DRIVE MARKET              210

TABLE 256         PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY REGION, 2021–2028 (USD MILLION)            211

TABLE 257         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)              211

TABLE 258         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)     212

TABLE 259         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)     212

TABLE 260         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)              212

7.4         PARENTERAL FORMULATIONS 213

7.4.1      EMERGENCE OF NEW BIOLOGICAL MOLECULES TO INCREASE DEMAND FOR EXCIPIENTS        213

TABLE 261         TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS              213

TABLE 262         EXCIPIENTS USED IN PARENTERAL FORMULATIONS    214

TABLE 263         PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2021–2028 (USD MILLION)            215

TABLE 264         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)              215

TABLE 265         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)              215

TABLE 266         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)              216

TABLE 267         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)              216

7.5         OTHER FORMULATIONS            216

TABLE 268         PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY REGION, 2021–2028 (USD MILLION)            217

TABLE 269         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 217

TABLE 270         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)        218

TABLE 271         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)        218

TABLE 272         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 218

8            PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 219

8.1         INTRODUCTION            220

TABLE 273         PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     220

8.2         FILLERS & DILUENTS    220

8.2.1      IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW PROPERTIES TO SUPPORT ADOPTION 220

TABLE 274         FILLERS & DILUENTS MARKET, BY REGION, 2021–2028 (USD MILLION)          221

TABLE 275         NORTH AMERICA: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    222

TABLE 276         EUROPE: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     222

TABLE 277         ASIA PACIFIC: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          222

TABLE 278         LATIN AMERICA: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          223

8.3         SUSPENDING & VISCOSITY AGENTS      223

8.3.1      DRUG STABILITY AND TASTE-MASKING ADVANTAGES TO SUPPORT DEMAND           223

TABLE 279         SUSPENDING & VISCOSITY AGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)          224

TABLE 280         NORTH AMERICA: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         224

TABLE 281         EUROPE: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    224

TABLE 282         ASIA PACIFIC: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    225

TABLE 283         LATIN AMERICA: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            225

8.4         COATING AGENTS        225

8.4.1      INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN PHARMA INDUSTRY TO DRIVE MARKET             225

TABLE 284         COATING AGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)          227

TABLE 285         NORTH AMERICA: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          227

TABLE 286         EUROPE: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 227

TABLE 287         ASIA PACIFIC: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          228

TABLE 288         LATIN AMERICA: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          228

8.5         BINDERS            228

8.5.1      FLUIDITY AND COMPRESSIBILITY IN TABLET MANUFACTURING TO DRIVE DEMAND             228

TABLE 289         BINDERS MARKET, BY REGION, 2021–2028 (USD MILLION)              229

TABLE 290         NORTH AMERICA: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 230

TABLE 291         EUROPE: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          230

TABLE 292         ASIA PACIFIC: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 230

TABLE 293         LATIN AMERICA: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 231

8.6         FLAVORING AGENTS & SWEETENERS   231

8.6.1      NEED TO IMPROVE DRUG PALATABILITY TO SUPPORT USAGE 231

TABLE 294         FLAVORING AGENTS & SWEETENERS MARKET, BY REGION, 2021–2028 (USD MILLION)          232

TABLE 295         NORTH AMERICA: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         232

TABLE 296         EUROPE: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    232

TABLE 297         ASIA PACIFIC: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            233

TABLE 298         LATIN AMERICA: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         233

8.7         DISINTEGRANTS           233

8.7.1      NEED TO ENSURE RAPID BREAK-UP OF SOLID DOSAGE FORMS TO DRIVE ADOPTION         233

TABLE 299         DISINTEGRANTS MARKET, BY REGION, 2021–2028 (USD MILLION)          234

TABLE 300         NORTH AMERICA: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          234

TABLE 301         EUROPE: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 235

TABLE 302         ASIA PACIFIC: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     235

TABLE 303         LATIN AMERICA: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          235

8.8         COLORANTS     236

8.8.1      APPLICATIONS IN HARD AND SOFT GELATIN CAPSULES, TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS TO DRIVE MARKET       236

TABLE 304         COLORANTS MARKET, BY REGION, 2021–2028 (USD MILLION)              237

TABLE 305         NORTH AMERICA: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     237

TABLE 306         EUROPE: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          237

TABLE 307         ASIA PACIFIC: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 238

TABLE 308         LATIN AMERICA: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     238

8.9         LUBRICANTS & GLIDANTS         238

8.9.1      NEED TO LESSEN WEAR AND TEAR ON FORMULATIONS TO SUPPORT LUBRICANT USAGE       238

TABLE 309         LUBRICANTS & GLIDANTS MARKET, BY REGION, 2021–2028 (USD MILLION) 239

TABLE 310         NORTH AMERICA: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    239

TABLE 311         EUROPE: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          240

TABLE 312         ASIA PACIFIC: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    240

TABLE 313         LATIN AMERICA: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    240

8.10       PRESERVATIVES            241

8.10.1    PRESERVATIVES TO SEE SUSTAINED USAGE TO ENSURE LONGER SHELF-LIFE       241

TABLE 314         PRESERVATIVES MARKET, BY REGION, 2021–2028 (USD MILLION)          241

TABLE 315         NORTH AMERICA: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          242

TABLE 316         EUROPE: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 242

TABLE 317         ASIA PACIFIC: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     242

TABLE 318         LATIN AMERICA: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          243

8.11       EMULSIFYING AGENTS 243

8.11.1    HIGH USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID FORMULATIONS TO DRIVE MARKET     243

TABLE 319         EMULSIFYING AGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)          244

TABLE 320         NORTH AMERICA: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    244

TABLE 321         EUROPE: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     244

TABLE 322         ASIA PACIFIC: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          245

TABLE 323         LATIN AMERICA: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    245

8.12       OTHER FUNCTIONALITIES        245

TABLE 324         PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2021–2028 (USD MILLION)        247

TABLE 325         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)              247

TABLE 326         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)    247

TABLE 327         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)    248

TABLE 328         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)              248

9            PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION  249

9.1         INTRODUCTION            250

TABLE 329         PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       250

9.2         STABILIZERS    250

9.2.1      IMPROVED DRUG SHELF LIFE AND REDUCED MANUFACTURING DEFECTS TO DRIVE MARKET    250

TABLE 330         PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2021–2028 (USD MILLION)  251

TABLE 331         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)       251

TABLE 332         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 252

TABLE 333         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION) 252

TABLE 334         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)       252

9.3         TASTE MASKING            253

9.3.1      GREATER PATIENT COMPLIANCE AND ADHERENCE ADVANTAGES TO ENSURE ADOPTION      253

TABLE 335         PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2021–2028 (USD MILLION)           253

TABLE 336         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION) 254

TABLE 337         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION)       254

TABLE 338         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION)        254

TABLE 339         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION) 255

9.4         MODIFIED RELEASE      255

9.4.1      INCREASING USE OF MODIFIED-RELEASE FORMULATIONS TO DRIVE MARKET            255

TABLE 340         PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2021–2028 (USD MILLION)            256

TABLE 341         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION)        256

TABLE 342         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION)  256

TABLE 343         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION)  257

TABLE 344         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION)        257

9.5         SOLUBILITY & BIOAVAILABILITY ENHANCEMENT         257

9.5.1      SOLUBILITY & BIOAVAILABILITY ENHANCEMENT EXCIPIENTS ESSENTIAL FOR EFFECTIVE DRUG DELIVERY    257

TABLE 345         PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY REGION, 2021–2028 (USD MILLION)          258

TABLE 346         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION)              259

TABLE 347         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION)              259

TABLE 348         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION)              259

TABLE 349         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION)              260

9.6         OTHER FUNCTIONALITY APPLICATIONS           260

TABLE 350         PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)              260

TABLE 351         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)          261

TABLE 352         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)          261

TABLE 353         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)          261

TABLE 354         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)          262

10          PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION  263

10.1       INTRODUCTION            264

TABLE 355         PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021–2028 (USD MILLION)     264

10.2       EUROPE             264

FIGURE 28         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT              265

10.2.1    EUROPE: RECESSION IMPACT   266

TABLE 356         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    266

TABLE 357         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   266

TABLE 358         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       267

TABLE 359         EUROPE: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          267

TABLE 360         EUROPE: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          267

TABLE 361         EUROPE: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              268

TABLE 362         EUROPE: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          268

TABLE 363         EUROPE: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 268

TABLE 364         EUROPE: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          269

TABLE 365         EUROPE: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)          269

TABLE 366         EUROPE: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 269

TABLE 367         EUROPE: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          270

TABLE 368         EUROPE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     270

TABLE 369         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   270

TABLE 370         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     271

TABLE 371         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        271

TABLE 372         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   272

TABLE 373         EUROPE: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          272

TABLE 374         EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       272

10.2.2    GERMANY         273

10.2.2.1 Germany to hold largest market share in Europe          273

TABLE 375         GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   273

TABLE 376         GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       274

TABLE 377         GERMANY: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 274

TABLE 378         GERMANY: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 274

TABLE 379         GERMANY: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          275

TABLE 380         GERMANY: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 275

TABLE 381         GERMANY: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 275

TABLE 382         GERMANY: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          276

TABLE 383         GERMANY: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)          276

TABLE 384         GERMANY: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 276

TABLE 385         GERMANY: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          277

TABLE 386         GERMANY: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)          277

TABLE 387         GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   277

TABLE 388         GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     278

TABLE 389         GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        278

TABLE 390         GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)      279

TABLE 391         GERMANY: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          279

TABLE 392         GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       279

10.2.3    UK         280

10.2.3.1 Growing adoption of generics and development of multi-functional, co-processed excipients to drive market  280

TABLE 393         UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          280

TABLE 394         UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)            281

TABLE 395         UK: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          281

TABLE 396         UK: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          281

TABLE 397         UK: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              282

TABLE 398         UK: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          282

TABLE 399         UK: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          282

TABLE 400         UK: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)              283

TABLE 401         UK: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              283

TABLE 402         UK: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          283

TABLE 403         UK: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)              284

TABLE 404         UK: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 284

TABLE 405         UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)            284

TABLE 406         UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     285

TABLE 407         UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        285

TABLE 408         UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   286

TABLE 409         UK: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)              286

TABLE 410         UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       286

10.2.4    FRANCE             287

10.2.4.1 Large geriatric population to support market growth    287

TABLE 411         FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   287

TABLE 412         FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       288

TABLE 413         FRANCE: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          288

TABLE 414         FRANCE: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          288

TABLE 415         FRANCE: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              289

TABLE 416         FRANCE: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          289

TABLE 417         FRANCE: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 289

TABLE 418         FRANCE: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          290

TABLE 419         FRANCE: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              290

TABLE 420         FRANCE: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 290

TABLE 421         FRANCE: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          291

TABLE 422         FRANCE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     291

TABLE 423         FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   291

TABLE 424         FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     292

TABLE 425         FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        292

TABLE 426         FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   293

TABLE 427         FRANCE: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          293

TABLE 428         FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       293

10.2.5    ITALY   294

10.2.5.1 Budgetary constraints and restricted healthcare spending to impede growth              294

TABLE 429         ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   294

TABLE 430         ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       295

TABLE 431         ITALY: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          295

TABLE 432         ITALY: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          295

TABLE 433         ITALY: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              296

TABLE 434         ITALY: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          296

TABLE 435         ITALY: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          296

TABLE 436         ITALY: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          297

TABLE 437         ITALY: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              297

TABLE 438         ITALY: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          297

TABLE 439         ITALY: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)              298

TABLE 440         ITALY: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     298

TABLE 441         ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   298

TABLE 442         ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     299

TABLE 443         ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        299

TABLE 444         ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   300

TABLE 445         ITALY: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)              300

TABLE 446         ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       300

10.2.6    SPAIN   301

10.2.6.1 High consumption of biologics to support market growth           301

TABLE 447         SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   301

TABLE 448         SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       302

TABLE 449         SPAIN: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          302

TABLE 450         SPAIN: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          302

TABLE 451         SPAIN: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              303

TABLE 452         SPAIN: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          303

TABLE 453         SPAIN: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          303

TABLE 454         SPAIN: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          304

TABLE 455         SPAIN: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              304

TABLE 456         SPAIN: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          304

TABLE 457         SPAIN: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)              305

TABLE 458         SPAIN: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     305

TABLE 459         SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   305

TABLE 460         SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     306

TABLE 461         SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        306

TABLE 462         SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   307

TABLE 463         SPAIN: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)              307

TABLE 464         SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       307

10.2.7    REST OF EUROPE           308

TABLE 465         REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            308

TABLE 466         REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)             309

TABLE 467         REST OF EUROPE: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)     309

TABLE 468         REST OF EUROPE: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)     309

TABLE 469         REST OF EUROPE: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          310

TABLE 470         REST OF EUROPE: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)     310

TABLE 471         REST OF EUROPE: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)     310

TABLE 472         REST OF EUROPE: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 311

TABLE 473         REST OF EUROPE: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)          311

TABLE 474         REST OF EUROPE: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)     311

TABLE 475         REST OF EUROPE: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          312

TABLE 476         REST OF EUROPE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)             312

TABLE 477         REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)         312

TABLE 478         REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 313

TABLE 479         REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)  313

TABLE 480         REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)            314

TABLE 481         REST OF EUROPE: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 314

TABLE 482         REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)  314

10.3       NORTH AMERICA          315

10.3.1    NORTH AMERICA: RECESSION IMPACT 315

FIGURE 29         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT        316

TABLE 483         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            316

TABLE 484         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            317

TABLE 485         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)             317

TABLE 486         NORTH AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)     317

TABLE 487         NORTH AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)     318

TABLE 488         NORTH AMERICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          318

TABLE 489         NORTH AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)     318

TABLE 490         NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)     319

TABLE 491         NORTH AMERICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 319

TABLE 492         NORTH AMERICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)          319

TABLE 493         NORTH AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)     320

TABLE 494         NORTH AMERICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 320

TABLE 495         NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)             320

TABLE 496         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)         321

TABLE 497         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION) 321

TABLE 498         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)  322

TABLE 499         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)            322

TABLE 500         NORTH AMERICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 322

TABLE 501         NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)  323

10.3.2    US         323

10.3.2.1 US to dominate North American market        323

TABLE 502         US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          324

TABLE 503         US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)            324

TABLE 504         US: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          324

TABLE 505         US: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          325

TABLE 506         US: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              325

TABLE 507         US: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          325

TABLE 508         US: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          326

TABLE 509         US: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)              326

TABLE 510         US: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              326

TABLE 511         US: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          327

TABLE 512         US: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)              327

TABLE 513         US: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION) 327

TABLE 514         US: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)            328

TABLE 515         US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     328

TABLE 516         US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        329

TABLE 517         US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   329

TABLE 518         US: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)              329

TABLE 519         US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       330

10.3.3    CANADA            330

10.3.3.1 Strong growth of emerging markets and slowdown in new product approvals to hamper growth    330

TABLE 520         CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   331

TABLE 521         CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       331

TABLE 522         CANADA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          331

TABLE 523         CANADA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 332

TABLE 524         CANADA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          332

TABLE 525         CANADA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          332

TABLE 526         CANADA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 333

TABLE 527         CANADA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          333

TABLE 528         CANADA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)          333

TABLE 529         CANADA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 334

TABLE 530         CANADA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          334

TABLE 531         CANADA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     334

TABLE 532         CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   335

TABLE 533         CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     335

TABLE 534         CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        336

TABLE 535         CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   336

TABLE 536         CANADA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          336

TABLE 537         CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       337

10.4       ASIA PACIFIC    337

10.4.1    ASIA PACIFIC: RECESSION IMPACT        337

TABLE 538         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    338

TABLE 539         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   338

TABLE 540         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       339

TABLE 541         ASIA PACIFIC: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 339

TABLE 542         ASIA PACIFIC: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 339

TABLE 543         ASIA PACIFIC: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          340

TABLE 544         ASIA PACIFIC: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 340

TABLE 545         ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 340

TABLE 546         ASIA PACIFIC: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          341

TABLE 547         ASIA PACIFIC: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)          341

TABLE 548         ASIA PACIFIC: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 341

TABLE 549         ASIA PACIFIC: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          342

TABLE 550         ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)          342

TABLE 551         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   342

TABLE 552         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     343

TABLE 553         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        343

TABLE 554         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)      344

TABLE 555         ASIA PACIFIC: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          344

TABLE 556         ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       344

10.4.2    CHINA  345

10.4.2.1 Emphasis on generics and off-patent drugs to drive market        345

TABLE 557         CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   345

TABLE 558         CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       346

TABLE 559         CHINA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          346

TABLE 560         CHINA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          346

TABLE 561         CHINA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              347

TABLE 562         CHINA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          347

TABLE 563         CHINA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          347

TABLE 564         CHINA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          348

TABLE 565         CHINA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              348

TABLE 566         CHINA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          348

TABLE 567         CHINA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)              349

TABLE 568         CHINA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     349

TABLE 569         CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   349

TABLE 570         CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     350

TABLE 571         CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        350

TABLE 572         CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   351

TABLE 573         CHINA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          351

TABLE 574         CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       351

10.4.3    JAPAN  352

10.4.3.1 Rapid growth in geriatric population to drive demand for pharmaceuticals              352

TABLE 575         JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   352

TABLE 576         JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       353

TABLE 577         JAPAN: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          353

TABLE 578         JAPAN: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          353

TABLE 579         JAPAN: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              354

TABLE 580         JAPAN: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          354

TABLE 581         JAPAN: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          354

TABLE 582         JAPAN: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          355

TABLE 583         JAPAN: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              355

TABLE 584         JAPAN: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          355

TABLE 585         JAPAN: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)              356

TABLE 586         JAPAN: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     356

TABLE 587         JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   356

TABLE 588         JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     357

TABLE 589         JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        357

TABLE 590         JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   358

TABLE 591         JAPAN: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          358

TABLE 592         JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       358

10.4.4    INDIA   359

10.4.4.1 High generics production to support market growth     359

TABLE 593         INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   359

TABLE 594         INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       360

TABLE 595         INDIA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          360

TABLE 596         INDIA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          360

TABLE 597         INDIA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              361

TABLE 598         INDIA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          361

TABLE 599         INDIA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          361

TABLE 600         INDIA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          362

TABLE 601         INDIA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              362

TABLE 602         INDIA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          362

TABLE 603         INDIA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)              363

TABLE 604         INDIA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     363

TABLE 605         INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   363

TABLE 606         INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     364

TABLE 607         INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        364

TABLE 608         INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   365

TABLE 609         INDIA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)              365

TABLE 610         INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       365

10.4.5    SOUTH KOREA 366

10.4.5.1 Strong and growing pharma industry to ensure market growth   366

TABLE 611         SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   366

TABLE 612         SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       366

TABLE 613         SOUTH KOREA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)     367

TABLE 614         SOUTH KOREA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)     367

TABLE 615         SOUTH KOREA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          367

TABLE 616         SOUTH KOREA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 368

TABLE 617         SOUTH KOREA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)     368

TABLE 618         SOUTH KOREA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 368

TABLE 619         SOUTH KOREA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)          369

TABLE 620         SOUTH KOREA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)     369

TABLE 621         SOUTH KOREA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          369

TABLE 622         SOUTH KOREA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)          370

TABLE 623         SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   370

TABLE 624         SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     371

TABLE 625         SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        371

TABLE 626         SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)      372

TABLE 627         SOUTH KOREA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          372

TABLE 628         SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       372

10.4.6    REST OF ASIA PACIFIC  373

TABLE 629         REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        373

TABLE 630         REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)              374

TABLE 631         REST OF ASIA PACIFIC: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          374

TABLE 632         REST OF ASIA PACIFIC: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          374

TABLE 633         REST OF ASIA PACIFIC: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 375

TABLE 634         REST OF ASIA PACIFIC: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          375

TABLE 635         REST OF ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          375

TABLE 636         REST OF ASIA PACIFIC: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)     376

TABLE 637         REST OF ASIA PACIFIC: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION) 376

TABLE 638         REST OF ASIA PACIFIC: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          376

TABLE 639         REST OF ASIA PACIFIC: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION) 377

TABLE 640         REST OF ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)       377

TABLE 641         REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)              377

TABLE 642         REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)          378

TABLE 643         REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)             378

TABLE 644         REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)              379

TABLE 645         REST OF ASIA PACIFIC: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION) 379

TABLE 646         REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)              379

10.5       LATIN AMERICA             380

10.5.1    GROWING GERIATRIC POPULATION AND DISEASE PREVALENCE TO DRIVE MARKET 380

10.5.2    LATIN AMERICA: RECESSION IMPACT   380

TABLE 647         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    380

TABLE 648         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   381

TABLE 649         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)             381

TABLE 650         LATIN AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)     381

TABLE 651         LATIN AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)     382

TABLE 652         LATIN AMERICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          382

TABLE 653         LATIN AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)     382

TABLE 654         LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)     383

TABLE 655         LATIN AMERICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION) 383

TABLE 656         LATIN AMERICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)          383

TABLE 657         LATIN AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)     384

TABLE 658         LATIN AMERICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          384

TABLE 659         LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)             384

TABLE 660         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)         385

TABLE 661         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     385

TABLE 662         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        386

TABLE 663         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)            386

TABLE 664         LATIN AMERICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          386

TABLE 665         LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       387

10.5.3    BRAZIL 387

10.5.3.1 Brazil to hold largest share in LATAM market             387

TABLE 666         BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   387

TABLE 667         BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       388

TABLE 668         BRAZIL: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          388

TABLE 669         BRAZIL: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          388

TABLE 670         BRAZIL: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              389

TABLE 671         BRAZIL: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          389

TABLE 672         BRAZIL: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          389

TABLE 673         BRAZIL: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          390

TABLE 674         BRAZIL: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              390

TABLE 675         BRAZIL: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          390

TABLE 676         BRAZIL: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          391

TABLE 677         BRAZIL: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     391

TABLE 678         BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   391

TABLE 679         BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     392

TABLE 680         BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        392

TABLE 681         BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   393

TABLE 682         BRAZIL: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          393

TABLE 683         BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       393

10.5.4    REST OF LATIN AMERICA          394

TABLE 684         REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        394

TABLE 685         REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)              394

TABLE 686         REST OF LATIN AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)             395

TABLE 687         REST OF LATIN AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)             395

TABLE 688         REST OF LATIN AMERICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)     395

TABLE 689         REST OF LATIN AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          396

TABLE 690         REST OF LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)             396

TABLE 691         REST OF LATIN AMERICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          396

TABLE 692         REST OF LATIN AMERICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)     397

TABLE 693         REST OF LATIN AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)             397

TABLE 694         REST OF LATIN AMERICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)     397

TABLE 695         REST OF LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)    398

TABLE 696         REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)              398

TABLE 697         REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)          399

TABLE 698         REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)             399

TABLE 699         REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)              400

TABLE 700         REST OF LATIN AMERICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)     400

TABLE 701         REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)              400

10.6       MIDDLE EAST & AFRICA             401

10.6.1    MIDDLE EAST & AFRICA: RECESSION IMPACT   401

10.6.2    MIDDLE EAST  401

10.6.2.1 Growing attention from global players to favor growth of middle eastern markets              401

TABLE 702         MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   401

TABLE 703         MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       402

TABLE 704         MIDDLE EAST: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION) 402

TABLE 705         MIDDLE EAST: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION) 402

TABLE 706         MIDDLE EAST: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          403

TABLE 707         MIDDLE EAST: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION) 403

TABLE 708         MIDDLE EAST: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)     403

TABLE 709         MIDDLE EAST: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          404

TABLE 710         MIDDLE EAST: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)          404

TABLE 711         MIDDLE EAST: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)     404

TABLE 712         MIDDLE EAST: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          405

TABLE 713         MIDDLE EAST: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)          405

TABLE 714         MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   405

TABLE 715         MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     406

TABLE 716         MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        406

TABLE 717         MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)      407

TABLE 718         MIDDLE EAST: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          407

TABLE 719         MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       407

10.6.3    AFRICA 408

10.6.3.1 Rising urbanization, growing healthcare access to offer growth opportunities              408

TABLE 720         AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   408

TABLE 721         AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)       408

TABLE 722         AFRICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          409

TABLE 723         AFRICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)          409

TABLE 724         AFRICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)              409

TABLE 725         AFRICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)          410

TABLE 726         AFRICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          410

TABLE 727         AFRICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)          410

TABLE 728         AFRICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)              411

TABLE 729         AFRICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)          411

TABLE 730         AFRICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)          411

TABLE 731         AFRICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)     412

TABLE 732         AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)   412

TABLE 733         AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)     413

TABLE 734         AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)        413

TABLE 735         AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)   414

TABLE 736         AFRICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)          414

TABLE 737         AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)       414

11          COMPETITIVE LANDSCAPE       415

11.1       INTRODUCTION            415

11.2       KEY PLAYER STRATEGIES/RIGHT-TO-WIN         415

FIGURE 30         OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS              415

11.3       REVENUE SHARE ANALYSIS       416

FIGURE 31         REVENUE ANALYSIS OF KEY PLAYERS (2020–2022)          416

11.4       MARKET SHARE ANALYSIS         416

FIGURE 32         PHARMACEUTICAL EXCIPIENTS MARKET: MARKET SHARE ANALYSIS (2022)            417

TABLE 738         PHARMACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION 417

11.5       COMPANY EVALUATION MATRIX          418

11.5.1    STARS  419

11.5.2    EMERGING LEADERS    419

11.5.3    PERVASIVE PLAYERS     419

11.5.4    PARTICIPANTS 419

FIGURE 33         PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX, 2022      420

11.5.5    COMPANY FOOTPRINT 421

TABLE 739         PRODUCT FOOTPRINT (25 COMPANIES)           421

TABLE 740         REGIONAL FOOTPRINT (25 COMPANIES)           422

11.6       START-UP/SME EVALUATION MATRIX 423

11.6.1    PROGRESSIVE COMPANIES       423

11.6.2    STARTING BLOCKS       423

11.6.3    RESPONSIVE COMPANIES          423

11.6.4    DYNAMIC COMPANIES 423

FIGURE 34         PHARMACEUTICAL EXCIPIENTS MARKET: START-UP/SME MATRIX, 2022    424

11.6.5    COMPETITIVE BENCHMARKING            425

TABLE 741         PHARMACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS   425

TABLE 742         PHARMACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 426

11.7       COMPETITIVE SCENARIO AND TRENDS             426

11.7.1    PRODUCT LAUNCHES  426

TABLE 743         PHARMACEUTICAL EXCIPIENTS MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO DECEMBER 2023 426

11.7.2    DEALS  427

TABLE 744         PHARMACEUTICAL EXCIPIENTS MARKET: DEALS, JANUARY 2020 TO DECEMBER 2023            427

11.7.3    OTHER DEVELOPMENTS           428

TABLE 745         PHARMACEUTICAL EXCIPIENTS MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO DECEMBER 2023    428

12          COMPANY PROFILES    429

(Business overview, Products/Solutions/Services offered, Recent developments & MnM Vie

12.1       KEY PLAYERS   429

12.1.1    INTERNATIONAL FLAVORS & FRAGRANCES INC.            429

TABLE 746         INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW        429

FIGURE 35         INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT (2022)          430

12.1.2    BASF SE              433

TABLE 747         BASF SE: BUSINESS OVERVIEW 433

FIGURE 36         BASF SE: COMPANY SNAPSHOT (2022)  433

12.1.3    ASHLAND INC. 438

TABLE 748         ASHLAND INC.: BUSINESS OVERVIEW   438

FIGURE 37         ASHLAND INC.: COMPANY SNAPSHOT (2022)    439

12.1.4    EVONIK INDUSTRIES AG            444

TABLE 749         EVONIK INDUSTRIES AG: BUSINESS OVERVIEW 444

FIGURE 38         EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2022) 445

12.1.5    KERRY GROUP PLC        447

TABLE 750         KERRY GROUP PLC: BUSINESS OVERVIEW         447

FIGURE 39         KERRY GROUP PLC: COMPANY SNAPSHOT (2022)          448

12.1.6    ROQUETTE FRÈRES      450

TABLE 751         ROQUETTE FRÈRES: BUSINESS OVERVIEW         450

12.1.7    MERCK KGAA   456

TABLE 752         MERCK KGAA: BUSINESS OVERVIEW     456

FIGURE 40         MERCK KGAA: COMPANY SNAPSHOT (2022)      456

12.1.8    ASSOCIATED BRITISH FOODS PLC         459

TABLE 753         ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW              459

FIGURE 41         ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT (2022)   460

12.1.9    ADM     464

TABLE 754         ADM: BUSINESS OVERVIEW       464

FIGURE 42         ADM: COMPANY SNAPSHOT (2022)        465

12.1.10  WACKER CHEMIE AG    467

TABLE 755         WACKER CHEMIE AG: BUSINESS OVERVIEW      467

FIGURE 43         WACKER CHEMIE AG: COMPANY SNAPSHOT (2022)       468

12.1.11  AIR LIQUIDE     469

TABLE 756         AIR LIQUIDE: BUSINESS OVERVIEW       469

FIGURE 44         AIR LIQUIDE: COMPANY SNAPSHOT (2022)        470

12.1.12  DOW    473

TABLE 757         DOW: BUSINESS OVERVIEW      473

FIGURE 45         DOW: COMPANY SNAPSHOT (2022)       473

12.1.13  LUBRIZOL CORPORATION (BERKSHIRE HATHAWAY)    475

TABLE 758         LUBRIZOL CORPORATION: BUSINESS OVERVIEW          475

12.1.14  COLORCON      478

TABLE 759         COLORCON: BUSINESS OVERVIEW        478

12.1.15  DFE PHARMA   481

TABLE 760         DFE PHARMA: BUSINESS OVERVIEW     481

*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.

12.2       OTHER PLAYERS           485

12.2.1    INNOPHOS        485

12.2.2    J. RETTENMAIER & SÖHNE GMBH + CO KG        486

12.2.3    ACTYLIS            487

12.2.4    MEGGLE GMBH & CO. KG          490

12.2.5    FUJI CHEMICAL INDUSTRIES CO., LTD. 491

12.2.6    COREL PHARMA CHEM 491

12.2.7    BIOGRUND GMBH         492

12.2.8    NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD.      492

12.2.9    R.T. VANDERBILT HOLDING COMPANY, INC.    494

12.2.10  BENEO 495

13          APPENDIX         496

13.1       DISCUSSION GUIDE      496

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             500

13.3       CUSTOMIZATION OPTIONS      502

13.4       RELATED REPORTS       502

13.5       AUTHOR DETAILS         503